NCT00600977View on ClinicalTrials.gov

Liposomal Anthracyclin in the Treatment of Elderly ALL

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

October 31, 2006

Conditions
Acute Lymphoblastic Leukemia
Interventions
DRUG

Doxorubicine

9mg/m² J1 J4 2 COURSES

DRUG

Doxorubicine pegylated

40 MG/M² J1 2 courses

Trial Locations (1)

49000

Regional university hospital, Angers

All Listed Sponsors
lead

French Innovative Leukemia Organisation

OTHER

NCT00600977 - Liposomal Anthracyclin in the Treatment of Elderly ALL | Biotech Hunter | Biotech Hunter